The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality

Acta Obstetricia et Gynecologica Scandinavica

Volumn 83, Issue 11, 2004, Pages 1056-1060

  Raijmakers, Maarten T M ^a,d   De Galan Roosen, Tanja E M ^b   Schilders, Geurt W ^a   Merkus, Johannus M W M ^a   Steegers, Eric A P ^c   Peters, Wllbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b CPRLab   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Detoxification; Glutathione S transferase P1; Microsomal epoxide hydrolase; Perinatal mortality

Indexed keywords

EPOXIDE HYDROLASE; GENOMIC DNA; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE P1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CONGENITAL DISORDER; CONTROLLED STUDY; DETOXIFICATION; DNA DETERMINATION; EXON; FEMALE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MICROSOME; PERINATAL MORTALITY; PILOT STUDY; PLACENTA DISORDER; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STRESS;

ADULT; CASE-CONTROL STUDIES; EPOXIDE HYDROLASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GLUTATHIONE TRANSFERASE; HUMANS; INFANT MORTALITY; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; MALE; NETHERLANDS; OBSTETRIC LABOR, PREMATURE; PILOT PROJECTS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS;

EID: 7644233874     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-6349.2004.00455.x     Document Type: Article

References (22)

1. Richardus JH, Graafmans WC, Pal-de Bruin KM, Amelink-Verburg MP, Verloove-Vanhorick SP, Mackenbach JP. A European concerted action investigating the validity of perinatal mortality as an outcome indicator for the quality of antenatal and perinatal care. J Perinat Med 1997; 25: 313-24.
2. Graafmans WC, Richardus JH, Macfarlane A, Rebagliato M, Blondel B, Verloove-Vanhorick SP et al. Comparability of published perinatal mortality rates in Western Europe: the quantitative impact of differences in gestational age and birthweight criteria. Br J Obstet Gynaecol 2001; 108: 1237-45.
3. De Galan-Roosen AEM, Kuijpers JC, Van der Straaten PJC, Merkus JMWM. Evaluation of 239 cases of perinatal death using a fundamental classification system. Eur J Obstet Gynecol Reprod Biol 2002; 103: 37-42.
4. Seidegard J, DePierre JW. Microsomal epoxide hydrolase. Properties, regulation and function. Biochim Biophys Acta 1983; 695: 251-70.
5. Jourenkova-Mironova N, Mitrunen K, Bouchardy C, Dayer P, Benhamou S, Hirvonen A. High-activity microsomal epoxide hydrolase genotypes and the risk of oral, pharynx, and larynx cancers. Cancer Res 2000; 60: 534-6.
6. Raijmakers MTM, Bruggeman SWM, Steegers EAP, Peters WHM. Distribution of components of the glutathione detoxification system across the human placenta after uncomplicated vaginal deliveries. Placenta 2002; 23: 490-6.
7. Jauniaux E, Watson AL, Hempstock J, Bao Y-P, Skepper JN, Burton G. Onset of maternal arterial blood flow and placental oxidative stress. A possible factor in human early pregnancy failure. Am J Pathol 2000; 157: 2111-22.
8. Raijmakers MTM, Steegers EAP, Peters WHM. Glutathione S-transferases and thiol concentrations in embryonic and early fetal tissues. Hum Reprod 2001; 16: 2445-50.
9. Zusterzeel PLM, Peters WHM, Visser W, Hermsen KJM, Roelofs HMJ, Steegers EAP. A polymorphism in the gene for microsomal epoxide hydrolase is associated with pre-eclampsia. J Med Genet 2001; 38: 234-7.
10. Zusterzeel PLM, Visser W, Peters WHM, Merkus HWJM, Nelen WLDM, Steegers EAP. Polymorphism in the glutathione S-transferase P1 gene and risk for preeclampsia. Obstet Gynecol 2000; 96: 50-4.
11. Zusterzeel PLM, Nelen WLDM, Roelofs HMJ, Peters WHM, Blom HJ, Steegers EAP. Polymorphisms in biotransformation enzymes and the risk for recurrent early pregnancy loss. Mol Hum Reprod 2000; 6: 474-8.
12. Van Lieshout EMM, Roelofs HMJ, Dekker S, Mulder CJJ, Wobbes T, Jansen JBMJ et al. Polymorphic expression of the glutathione S-transferase P1 gene and its susceptibility to Barrett's esophagus and esophageal carcinoma. Cancer Res 1999; 59: 586-9.
13. Hassett C, Aicher L, Sidhu JS, Omiencinski CJ. Human microsomal epoxide hydrolase: genetic polymorphism and functional expression in vitro of amino acid variants. Hum Mol Genet 1994; 3: 421-8.
14. Zusterzeel PLM, Te Morsche RHM, Raijmakers MTM, Roes EM, Peters WHM, Steegers EAP. Paternal contribution to the risk for pre-eclampsia. J Med Genet 2002; 39: 44-5.
15. World Health Organization (WHO). Recommended definitions, terminology and format for statistical tables related to the perinatal period and use of a new certificate for causes of deaths. Acta Obstet Gynecol Scand 1977; 56: 247-53.
16. Smith CAD, Harrison DJ. Association between polymorphism in gene for microsomal epoxide hydrolase and susceptibility to emphysema. Lancet 1997; 350: 630-3.
17. Wang X, Wang M, Niu T, Chen C, Xu X. Microsomal epoxide hydrolase polymorphism and risk of spontaneous abortion. Epidemiology 1998; 9: 540-4.
18. Harrison DJ, Hubbard AL, MacMillan J, Wyllie AH, Smith CAD. Microsomal epoxide hydrolase gene polymorphism and susceptibility to colon cancer. Br J Cancer 1999; 79: 168-71.
19. Wong NACS, Rae F, Bathgate A, Smith CAD, Harrison DJ. Polymorphisms of the gene for microsomal epoxide hydrolase and susceptibility to alcoholic liver disease and hepatocellular carcinoma in a Caucasian population. Toxicol Lett 2000; 115: 17-22.
20. Benhamou S, Reinikainen M, Bouchardy C, Dayer P, Hirvonen A. Association between lung cancer and microsomal epoxide hydrolase genotypes. Cancer Res 1998; 58: 5291-3.
21. To-Figueras J, Gene M, Gomez-Catalan J, Pique E, Borrego N, Corbella J. Lung cancer susceptibility in relation to combined polymorphisms of microsomal epoxide hydrolase and glutathione S-transferase P1. Cancer Lett 2001; 173: 155-62.
22. Irani K. Oxidant signaling in vascular cell growth, death, and survival: a review of the roles of reactive oxygen species in smooth muscle and endothelial cell mitogenic and apoptotic signaling. Circ Res 2000; 87: 179-83.